Table 1:
Estimated frequency | |
---|---|
Age <21 years | 80–90% |
Prodromal fever or viral illness | 85–95% |
Neurological onset to nadir <10 days | 100% |
Headache or neck stiffness at onset | 12–60% |
Asymmetric onset of weakness | 65–95% |
Limb weakness | 85–95% |
Upper limb weakness | 60–85% |
Flaccidity or hyporeflexia of affected limbs | 95–100% |
Neck, face, extraocular, or bulbar weakness | 20–60% |
Trunk weakness | 30–70% |
Requirement for mechanical ventilation | 10–40% |
Bladder or bowel dysfunction | 5–40% |
Non-specific sensory symptoms (eg, paresthesia) | 10–20% |
Cardiovascular autonomic dysfunction | <10% |
CSF pleocytosis (with testing <5 days after | 85–95% |
Grey-matter predominant spinal cord lesion(s) on MRI | 95–100% |
Brainstem lesion(s) on MRI | 35–45% |
Cerebral deep grey matter lesion(s) on MRI | <5% |
CSF=cerebrospinal fluid.